Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Exchange Rate Effect (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Exchange Rate Effect for 17 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 119.83% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.0 million through Dec 2025, up 378.73% year-over-year, with the annual reading at $18.0 million for FY2025, 378.73% up from the prior year.
  • Exchange Rate Effect hit $1.6 million in Q4 2025 for Integra Lifesciences Holdings, up from -$801000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $12.7 million in Q2 2025 to a low of -$10.7 million in Q3 2022.
  • Historically, Exchange Rate Effect has averaged -$237850.0 across 5 years, with a median of -$507000.0 in 2023.
  • Biggest five-year swings in Exchange Rate Effect: plummeted 629.67% in 2024 and later soared 1226.93% in 2025.
  • Year by year, Exchange Rate Effect stood at $904000.0 in 2021, then skyrocketed by 1217.37% to $11.9 million in 2022, then plummeted by 32.5% to $8.0 million in 2023, then crashed by 201.04% to -$8.1 million in 2024, then skyrocketed by 119.83% to $1.6 million in 2025.
  • Business Quant data shows Exchange Rate Effect for IART at $1.6 million in Q4 2025, -$801000.0 in Q3 2025, and $12.7 million in Q2 2025.